Tag: Biomarker Trials

New Delhi: Access to genomic testing and matched treatments remains profoundly unequal within and between countries, according to a new commission by The Lancet Oncology. It has also identified substantial inequalities in cancer genetic testing research, reporting that only 2 per cent of biomarker-based cancer trials are conducted in low- and middle-income countries (LMICs), compared…

Continue Reading